According to Mallinckrodt Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is C$2.68 Billion. In 2022 the company made a revenue of C$2.59 Billion a decrease over the revenue in the year 2021 that were of C$2.81 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.